Skip to main content
AL

Attest Laboratories

Attest Laboratories develops a non-invasive magnetic resonance spectroscopy (MRS) system, myScanLab™, for the accurate testing of metabolite biomarkers like glucose and cholesterol through a simple finger scan. This technology addresses the need for frequent and painless monitoring of metabolic conditions, reducing costs and improving patient outcomes in healthcare settings.

Toronto, CanadaFounded 20172200+ followers
Updated 20 months ago

Funding

Funding not disclosed

PA
Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Current methods for monitoring metabolic biomarkers, such as glucose and cholesterol, often rely on invasive procedures like finger pricks, which can be painful and inconvenient for frequent testing. Existing continuous glucose monitors are not always suitable for individuals who require less frequent monitoring.

Solution

Attest Laboratories is developing myScanLab™, a non-invasive magnetic resonance spectroscopy (MRS) system designed for convenient and accurate testing of metabolite biomarkers. The system uses a simple finger scan to measure glucose, cholesterol, and other metabolites without breaking the skin or requiring disposable test strips. This approach enables more frequent spot-testing for screening and management of metabolic conditions, potentially improving patient outcomes and lowering recurring costs in point-of-care settings. The technology aims to provide a portable, user-friendly solution for healthcare providers and individuals managing conditions like diabetes.

Target Audience

The primary target audience includes healthcare providers, such as primary care practices and senior living facilities, as well as individuals with diabetes and other metabolic conditions requiring frequent biomarker monitoring.

Features

  • Non-invasive metabolite testing via magnetic resonance spectroscopy (MRS)
  • Measures glucose, cholesterol, and other biomarkers from a finger scan
  • Ultra-low noise spectrometer and probe design for optimal measurement sensitivity
  • Proprietary RF excitation pulse sequence and DFT-based resonance signal processing
  • Patent-pending gradient shimming technology for high spectral resolution
  • Patent-pending magnet array design for improved field strength and portability
  • Novel NMR probe design for spatially uniform RF excitation and high-sensitivity signal reception
This profile is AI-generated and may contain inaccuracies.